Skip to main content
Log in

Bullous mastocytosis treated with oral betamethasone therapy

  • Clinical Brief
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Bullous mastocytosis is a very rare variant of cutaneous mastocytosis. The condition is characterized by a diffuse infiltration of the skin by mast cells manifesting as yellowish, thickened doughy skin with appearance of large blisters. The authors report herewith a 7-month-old female infant with history of recurrent episodes of vesiculobullous lesions on the face, trunk and the extremities and excessive tendency to rub and scratch the skin for 3 months. She also had recurrent episodes of facial flushing. On cutaneous examination there were multiple flaccid bullae, urticarial wheals and crusted erosions on her scalp, face, neck, trunk and extremities. She had generalised yellowish thick and rough skin, giving doughy feel and ‘peaud orange’ appearance of the skin at places. Systemic examination was within normal limits. Skin biopsy from a lesion showed subepidermal bulla and an upper dermal inflammatory infiltrate comprising of lymphocytes and many mast cells. Toluidine blue staining of the cells showed presence of metachromatic granules in these cells. A diagnosis of bullous mastocytosis was made and the patient was treated with oral antihistamines to which there was no satisfactory response. Betamethasone in a dose of 0.1 mg/kg/day given orally caused complete remission of the disease in 4 weeks. The drug was gradually tapered and stopped over the next 6 weeks. There were no side effects of the therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Warin RP, Hughes RCW. Diffuse cutaneous mastocytosis. BrJ Dermatol 1963; 65: 296–297.

    Google Scholar 

  2. Milton O, Robert AG, Carlyle CCet al. Bullous mastocytosis.Arch Dermatol 1970; 101: 547–562.

    Article  Google Scholar 

  3. Hartman K, Henz BM. Mastocytosis: recent advances in defining the disease.Br J Dermatol 2001; 144: 682–695.

    Article  Google Scholar 

  4. Murphy M, Walsh D, Drumm Bet al. Bullous mastocytosis: a fatal outcome.Pediatr Dermatol 1999; 16: 452–455.

    Article  PubMed  CAS  Google Scholar 

  5. Cook J, Stith M, Sahn EE. Bullous mastocytosis in an infant associated with the use of a nonprescription cough suppressant.Pediatr Dermatol 1996; 13:410–414.

    PubMed  CAS  Google Scholar 

  6. Shah PY, Sharma V, Worobec ASet al. Congenital bullous mastocytosis with myeloproliferative disorder and c-kit mutation.J Am Acad Dermatol 1998; 39:119–121.

    PubMed  CAS  Google Scholar 

  7. Gerrard JW. Urticaria pigmentoga: treated with cimetidine and chlorpheniramine.J Paediatr 1979; 94: 843–844.

    Article  CAS  Google Scholar 

  8. Soter NA, Austen KF, Wasserman SI. Oral disodium cromoglycate in the teatment of systemic mastocytosis.N Engl J Med 1979; 301: 465–469.

    Article  PubMed  CAS  Google Scholar 

  9. Evans S, Vickers CFH. Bullous urticaria pigmentosa (cutaneous) and sodium cromoglycate.Acta Dermatol Venereol 1981; 61: 572–575.

    CAS  Google Scholar 

  10. Mackie S, Pride HB, Tyler WBet al. Diffuse cutaneous mastocytosis: treatment with oral psoralens plus UV-A.Arch Dermatol 1996; 132:1429–1430.

    Article  Google Scholar 

  11. Vella Briffa D, Eady RAJ, James MPet al. Photochemotherapy (PUVA) in the treatment of urticaria pigmentosa.Br J Dermatol 1983; 109:67–75.

    Article  PubMed  CAS  Google Scholar 

  12. Crawhall IC, Wiskinson RD. Systemic mastocytosis: management of an unusual case with histamine (H1 and H2) antagonists and cyclooxygenase inhibition.Clin Invest Med 1987; 10: 1–4.

    PubMed  CAS  Google Scholar 

  13. Delaporte E, Pierard E, Wolthers BGet al. Interferon-alpha in combination with corticosteroids improves systemic mast cell disease.Br J Dermatol 1995; 132: 479–482.

    Article  PubMed  CAS  Google Scholar 

  14. Barton J, Lavker RM, Schechter NM, Lazarus GS. Treatment of urticaria pigmentosa with corticosteroids.Arch Dermatol 1985; 121: 1516–1523.

    Article  PubMed  CAS  Google Scholar 

  15. Guzzo C, Lavker R, Rosert LJet al. Urticaria pigmentosa: systemic evaluation and successful treatment with topical steroids.Arch Dermatol 1991; 127:191–196.

    Article  PubMed  CAS  Google Scholar 

  16. Blauvelt A, Kerdel FA. Intravenous corticosteroids for systemic mastocytosis.Arch Dermatol 1991; 127:191–196.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kaushal K. Verma.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verma, K.K., Bhat, R. & Singh, M.K. Bullous mastocytosis treated with oral betamethasone therapy. Indian J Pediatr 71, 261–263 (2004). https://doi.org/10.1007/BF02724280

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02724280

Key words

Navigation